We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.68B
AUM Growth
+$43.8M
Cap. Flow
-$77.1M
Cap. Flow %
-2.88%
Top 10 Hldgs %
33.94%
Holding
121
New
7
Increased
28
Reduced
73
Closed
5

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$19.5M
2
CORT icon
Corcept Therapeutics
CORT
+$15.5M
3
GTLS
Chart Industries
GTLS
+$14M
4
TGTX icon
TG Therapeutics
TGTX
+$12.7M
5
EHC icon
Encompass Health
EHC
+$10.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.9M
2
APP icon
Applovin
APP
+$23.4M
3
UBER icon
Uber
UBER
+$22.7M
4
IQV icon
IQVIA
IQV
+$11.8M
5
VRT icon
Vertiv
VRT
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 29.33%
2 Financials 13.75%
3 Communication Services 12.62%
4 Consumer Discretionary 10.61%
5 Healthcare 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTD icon
26
Trade Desk
TTD
$6.49B
$29.8M 1.11%
253,726
-8,963
-3% -$1.11M
WFC icon
27
Wells Fargo
WFC
$264B
$28.8M 1.08%
409,900
+23,035
+6% +$1.57M
TXRH icon
28
Texas Roadhouse
TXRH
$13.7B
$28.4M 1.06%
157,534
-2,625
-2% -$494K
TJX icon
29
TJX Companies
TJX
$178B
$28.2M 1.05%
233,355
+8,086
+4% +$965K
FWONK icon
30
Liberty Media Series C
FWONK
$25.8B
$28.1M 1.05%
303,432
-6,327
-2% -$537K
MRVL icon
31
Marvell Technology
MRVL
$196B
$28M 1.05%
253,554
+25,676
+11% +$2.38M
ETR icon
32
Entergy
ETR
$50B
$27.3M 1.02%
360,502
-21,480
-6% -$1.55M
PANW icon
33
Palo Alto Networks
PANW
$297B
$27.3M 1.02%
150,017
-3,037
-2% -$574K
TRV icon
34
Travelers Companies
TRV
$80.2B
$27M 1.01%
112,216
+348
+0.3% +$86.9K
BRBR icon
35
BellRing Brands
BRBR
$1.34B
$25.8M 0.96%
342,606
+34,959
+11% +$2.48M
LDOS icon
36
Leidos
LDOS
$17.3B
$25.3M 0.94%
175,373
-5,196
-3% -$865K
MANH icon
37
Manhattan Associates
MANH
$11.4B
$25.2M 0.94%
93,311
-5,664
-6% -$1.61M
BLK icon
38
Blackrock
BLK
$176B
$24.6M 0.92%
24,014
+190
+0.8% +$193K
AZO icon
39
AutoZone
AZO
$51.1B
$24.4M 0.91%
7,629
+500
+7% +$1.58M
MAR icon
40
Marriott International
MAR
$92.3B
$24M 0.89%
85,890
+5,745
+7% +$1.58M
BSX icon
41
Boston Scientific
BSX
$71.5B
$23.9M 0.89%
267,743
-3,513
-1% -$309K
POST icon
42
Post Holdings
POST
$3.57B
$23.6M 0.88%
206,561
+7,086
+4% +$807K
ITRI icon
43
Itron
ITRI
$4.54B
$23.5M 0.88%
216,769
-1,640
-0.8% -$183K
TRGP icon
44
Targa Resources
TRGP
$55.1B
$23.5M 0.88%
131,589
+56,984
+76% +$10.2M
CL icon
45
Colgate-Palmolive
CL
$74.4B
$22.8M 0.85%
250,787
+19,967
+9% +$1.91M
ACGL icon
46
Arch Capital
ACGL
$33.6B
$22.7M 0.85%
246,271
-4,047
-2% -$409K
COST icon
47
Costco
COST
$420B
$22.6M 0.85%
24,712
-1,943
-7% -$1.8M
MCK icon
48
McKesson
MCK
$101B
$22.1M 0.82%
38,755
-7,696
-17% -$4.31M
WEC icon
49
WEC Energy
WEC
$35.1B
$21.9M 0.82%
232,905
-5,785
-2% -$561K
LRCX icon
50
Lam Research
LRCX
$390B
$21.7M 0.81%
300,035
-26,265
-8% -$1.99M
1
2
3 4 5

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return

Braun Stacey Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Braun Stacey Associates held 121 positions worth $2.68B, up 1.7% from $2.63B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Braun Stacey Associates's Q4 2024 filing shows 7 new, 28 increased, 73 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb: 348,518 shares worth $19.7M. The largest sale was Merck, an estimated $24.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q4 2024 buy was Bristol-Myers Squibb: 348,518 shares worth $19.7M.
  • Braun Stacey Associates added most to Targa Resources in Q4 2024, an estimated $10.2M increase.
  • Braun Stacey Associates's biggest Q4 2024 reduction was Applovin, cutting an estimated $23.4M.
  • Braun Stacey Associates fully exited Merck in Q4 2024, selling an estimated $24.9M.
  • Braun Stacey Associates's ten largest holdings make up 34% of its $2.68B portfolio in Q4 2024.
  • Braun Stacey Associates opened 7 new positions and closed 5 in Q4 2024.
  • Braun Stacey Associates's portfolio value rose 1.7% quarter-over-quarter to $2.68B.

Based on Braun Stacey Associates's 13F filing for Q4 2024, filed 31 Jan 2025.